Data Year:
Select Other Years

For its 2024 fiscal year, MERIT MEDICAL SYSTEMS INC, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2024
Name And Title Total Compensation Pay Rank By Title In MFG Durable industry
Fred P. Lampropoulos
Chair of the Board, CEO and President
Total Compensation $10,381,624 View details Pay Rank By Title In MFG Durable industry #171 View more
Joseph C. Wright
Former President
Total Compensation $3,383,443 View details Pay Rank By Title In MFG Durable industry #47 View more
Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Total Compensation $3,102,704 View details Pay Rank By Title In MFG Durable industry #38 View more
Raul Parra
Chief Financial Officer and Treasurer
Total Compensation $3,169,011 View details Pay Rank By Title In MFG Durable industry #213 View more
Neil W. Peterson
Chief Operating Officer
Total Compensation $3,137,370 View details Pay Rank By Title In MFG Durable industry #62 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at MERIT MEDICAL SYSTEMS INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. MERIT MEDICAL SYSTEMS INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. MERIT MEDICAL SYSTEMS INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Fred P. Lampropoulos
Chair of the Board, CEO and President
Total Cash $3,238,326 Equity $7,132,948 Other $10,350 $10,381,624
Joseph C. Wright
Former President
Total Cash $1,174,721 Equity $2,124,680 Other $84,042 $3,383,443
Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Total Cash $929,628 Equity $2,124,680 Other $48,396 $3,102,704
Raul Parra
Chief Financial Officer and Treasurer
Total Cash $1,004,535 Equity $2,124,680 Other $39,796 $3,169,011
Neil W. Peterson
Chief Operating Officer
Total Cash $929,628 Equity $2,124,680 Other $83,062 $3,137,370
For its 2024 fiscal year, MERIT MEDICAL SYSTEMS INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Fred P. Lampropoulos CEO Pay $10,381,624 Median Employee Pay $35,793 CEO Pay Ratio 290:1
For its 2024 fiscal year, MERIT MEDICAL SYSTEMS INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
A. Scott Anderson Total Cash $37,875
David K. Floyd Total Cash $295,349
F. Ann Millner, Ed.D Total Cash $330,974
Laura S. Kaiser Total Cash $285,974
Lonny J. Carpenter Total Cash $300,974
Lynne N. Ward Total Cash $305,974
Michael R. McDonnell Total Cash $285,974
Silvia M. Perez Total Cash $253,724
Stephen C. Evans Total Cash $285,974
Thomas J. Gunderson Total Cash $300,974
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.